SNY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Sanofi's annual construction in progress declined from Dec. 2011 ($2,902 Mil) to Dec. 2012 ($2,706 Mil) and declined from Dec. 2012 ($2,706 Mil) to Dec. 2013 ($0 Mil).
It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Sanofi Annual Data
Sanofi Quarterly Data